Clinical Trial Update: Use of Oral Probiotics to Reduce Urinary Oxalate Excretion [Phase 1, Phase 2]

View source ↗

Summary

A Mayo Clinic-sponsored phase 1/2 clinical trial assessed an oral probiotic to lower urinary oxalate excretion in nephrolithiasis and hyperoxaluria, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria
• Nephrolithiasis

Drugs mentioned

• Oral probiotic formulation (probiotic)

Snippet

Sponsor: Mayo Clinic | Conditions: Nephrolithiasis, Hyperoxaluria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-05-31